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2D DIGECystathionine b-synthase-deﬁcient (Cbs/) mice, an animal model for homocystinuria, exhibit hep-
atic steatosis and juvenile semilethality via as yet unknown mechanisms. The plasma protein proﬁle
of Cbs/ mice was investigated by proteomic analysis using two-dimensional difference gel
electrophoresis and matrix-assisted laser desorption/ionization-time of ﬂight/mass spectrometry.
We found hyperaccumulation of a-fetoprotein (AFP) and downregulation of most other plasma
proteins. AFP was highly expressed in fetal liver, but its expression declined dramatically via
transcriptional repression after birth in both wild-type and Cbs/ mice. However, the repression
was delayed in Cbs/ mice, causing high postnatal AFP levels, which may relate to transcriptional
repression of most plasma proteins originating from liver and the observed hepatic dysfunction.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Elevated levels of plasma homocysteine are an independent risk
factor for atherosclerotic cardiovascular diseases, stroke, periph-
eral arterial occlusive diseases, and venous thrombosis [1].
Hyperhomocysteinemia is caused by several genetic defects, but
mainly by deﬁciency of cystathionine b-synthase (CBS; EC
4.2.1.22). CBS-deﬁcient homocystinuria patients (MIM 236200)
exhibit various severe clinical manifestations including throm-
boembolism, mental retardation, osteoporosis, and skeletal abnor-
malities. The molecular mechanisms by which accumulated
homocysteine may promote such diseases have been the focus of
numerous investigations. Endothelial dysfunction appears to play
a key role in cardiovascular diseases [2], but the pathogenesis ofhepatic steatosis, a sporadic feature in CBS-deﬁcient patients
[1,3], remains to be clariﬁed. It is notable that plasma homocys-
teine levels are elevated in patients with non-alcoholic fatty liver
disease (NAFLD) [4].
A genetic model with targeted deletion of the Cbs gene was gen-
erated in 1995 [5] and has subsequently been widely used in
homocysteine-related research. Homozygous Cbs/ mice develop
fatty liver at a juvenile age (2 weeks old) [5,6] and display an
abnormal lipoprotein proﬁle [7], but a few escape and fortunately
survive beyond this age [8]. This study examined the plasma pro-
tein proﬁle of Cbs/ mice using proteomic analysis with ﬂuores-
cent two-dimensional difference gel electrophoresis (2D DIGE) to
gain insight into the molecular background of hepatic steatosis.
For comparison, we utilized mice lacking cystathionine c-lyase
(CTH, also known as CSE; EC 4.4.1.1), which also display homocys-
teinemia but are free of obvious abnormalities (such as fatty liver)
[9]. Here, we found hyperaccumulation of a-fetoprotein (AFP) in
the plasma and fatty liver of Cbs/ mice but not of Cth/ mice.
2. Materials and methods
2.1. Animals
Heterozygous Cbs+/ mice in a C57BL/6J background
(B6.129P2-Cbstm1Unc/J) were obtained from the Jackson Laboratory
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erations (N12) with C57BL/6JJcl (Jcl: Japan Clea, Tokyo, Japan) [8].
Heterozygous Cth+/ mice were generated by our group [9] and
backcrossed for 10 generations (N10) with C57BL/6JJcl [10]. N12
Cbs+/ or N10 Cth+/micewere bred to produce Cbs/ or Cth/mice,
and their age-matched progenies were analyzed comparatively.
Mice were housed in an air-conditioned room kept on a 12-h
dark/light cycle and allowed to free access to a standard dry
rodent diet and water. All animal protocols were approved by
the Animal Care Committee of Keio University (No. 09187-(4)).
2.2. Polyacrylamide gel electrophoresis (PAGE) and western blotting
Male mice were anesthetized with diethyl ether, and blood
samples were collected from beating hearts of laparotomized mice,
and then EDTA plasma (or serum) was prepared. Livers were
removed quickly and frozen in liquid nitrogen until homogeniza-
tion in ice-cold phosphate buffer containing Complete Mini,
EDTA-free protease inhibitor cocktail (Roche Applied Science)
[11]. Serum or liver homogenates (2.5 lg; quantiﬁed using Pierce
BCA Protein Assay Kit, Thermo Scientiﬁc) were separated on a
10% SDS–PAGE gel and transferred to a polyvinylidene ﬂuoride
membrane (Immobilon-P, 0.45 lm, Millipore). The membranes
were subjected to Western blotting analysis using goat
anti-AFP antibody (1:200 dilution; sc-8108; Santa Cruz),
anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) anti-
body (1:1,000 dilution; #2118; Cell Signaling), horseradish
peroxidase-conjugated anti-goat IgG (H+L) antibody (1:2,000 dilu-
tion; PI-9500; Vector Laboratories), and an ECL Prime detection
system (GE Healthcare).
2.3. Measurement of plasma albumin levels
Plasma levels of albumin were measured using a Dri-Chem
7000i biochemistry analyzer with ALB-P slides (Fujiﬁlm, Tokyo,
Japan).
2.4. 2D DIGE
Plasma (10 lL) was mixed with 90 lL lysis buffer (7 M urea, 2 M
thiourea, 4% CHAPS, 1 mM PMSF, 1 mM Na3VO4). After adjusting
the pH to 8.5 by adding 10 mM Tris–HCl (pH 8.5), 0.8 lL samples
were labeled with 200 pmol of CyDye DIGE ﬂuor, minimal labeling
dye (Cy2, Cy3 or Cy5 [GE Healthcare]) at 4 C for 30 min in the
dark. The reaction was stopped by adding 0.5 lL of 10 mM lysine.
Labeled samples were mixed with dithiothreitol (DTT) and immo-
bilized pH gradient (IPG) buffer (ﬁnal 1% each) at 4 C for 10 min in
the dark. The samples were immediately subjected to isoelectric
focusing (IEF) in an Immobiline DryStrip (13 cm, pH 4–7 [GE
Healthcare]) that were rehydrated for 20 h in a rehydration buffer
(7 M urea, 2 M thiourea, 2% Triton X-100, 13 mM DTT, 2.5 mM
acetic acid, 1% IPG buffer, and a trace amount of bromophenol
blue) at 20 C. IEF was performed using a CoolPhoreStar IPG-IEF
Type-PX system (Anatech, Tokyo, Japan) in the following condi-
tions: 500 V for 1.5 h, linear gradient from 500 V to 3500 V for
4.5 h, and ﬁnally 3500 V for 8 h at 20 C. Once IEF was completed,
the strips were equilibrated for 30 min in reducing buffer (50 mM
Tris–HCl [pH 6.8], 6 M urea, 2% SDS, 30% [v/v] glycerol, 65 mM DTT
and a trace amount of bromophenol blue), followed by an alkylat-
ing buffer (reducing buffer with 4.5% iodoacetamide instead of
DTT) for an additional 15 min. The strips were sealed on the top
of 10% PAGE gels using 0.5% low-melting-point agarose in a
Tris–glycine electrophoresis buffer. The second dimension of protein
separation was performed at a constant 200 V using an ERICA-S
high-speed electrophoresis system (DRC, Tokyo, Japan) [12]. Gels
were scanned using a Typhoon Trio image scanner (GE Healthcare).2.5. Matrix-assisted laser desorption/ionization-time of ﬂight/mass
spectrometry (MALDI-TOF/MS) analysis
For silver staining, plasma (10 lL) was subjected to IEF and then
SDS–PAGE without CyDye labeling. The gel was stained using a
Silver Stain MS kit (Wako, Tokyo, Japan) in accordance with the
manufacturer’s instructions. The gel pieces were excised,
destained, washed twice with deionized water and four times with
50 mM ammonium bicarbonate: acetonitrile (1:1), and dehydrated
once with acetonitrile. Then, the gel pieces were twice alternately
rehydrated with 100 mM ammonium bicarbonate and dehydrated
with acetonitrile, and dried by vacuum centrifugation. Protein
samples were digested at 37 C for 12 h with 5 lL of 0.02 lg/lL
Sequencing Grade Modiﬁed Trypsin (Promega) dissolved in
25 mM ammonium bicarbonate. Peptides were extracted from
the gels in 40 lL of 1% triﬂuoroacetic acid/50% acetonitrile solution
by sonication. Samples were spotted onto a lFocus MALDI plate
(900 lm, 384 circles, Hudson Surface Technology; Old Tappan,
NJ, USA) with an equal volume of matrix solution, containing
10 mM a-cyano-4-hydroxycinnamic acid in 1% triﬂuoroacetic
acid/50% acetonitrile. Positive ion mass spectra were obtained
using an AXIMA-CFR Plus (Shimadzu, Kyoto, Japan) in a reﬂectron
mode. MS spectra were acquired over a mass range of 700–
4000 m/z and calibrated using peptide calibration standards
(1,000–3,200 Da, Bruker Daltonics, Yokohama, Japan) [12].
2.6. Protein database search
Proteins were identiﬁed by matching the peptide mass ﬁnger-
print with the Swiss-Prot protein database using the MASCOT
Search engine (Matrix Science, http://www.matrixscience.com).
Database searches were carried out using the following parame-
ters: taxonomy, Mus musculus; enzyme, trypsin; and allowing
one missed cleavage. Carbamidomethylation was selected as a
ﬁxed modiﬁcation, and the oxidation of methionine was allowed
as a variable. The peptide mass tolerance was set at 0.5 Da and
the signiﬁcance threshold was set at P < 0.05 probability based val-
ues on Mowse scores (P55).
2.7. Quantitative polymerase chain reaction (qPCR)
Total RNA was isolated from the liver using TRI Reagent
(Molecular Research Center, Cincinnati, Ohio, USA). Total RNA
(1 lg) was used to produce ﬁrst-strand cDNA with a ReverTra
Ace qPCR RT Kit (Toyobo, Tokyo, Japan). A total of 10 ng of cDNA
from each sample was ampliﬁed via qPCR using the SYBR Green
Realtime PCR Master Mix (Toyobo), 18 primer sets (Table 1), and
a CFX96 Touch Real-Time PCR Detection System (Bio-Rad) [11].
Each mRNA level was quantiﬁed using the comparative CT method
with housekeeping gene hypoxanthine guanine phosphoribosyl
transferase (Hprt) levels used for normalization, and the relative
expression in wild-type mice was set at 1.
2.8. Statistical analysis
Data are expressed as means ± SD of independent samples (n as
indicated). Statistical analyses were performed using unpaired
two-tailed Student’s t-test, where P values 60.05 were considered
signiﬁcant.
3. Results
3.1. Plasma protein proﬁling by 2D DIGE
Cbs/ mice suffer from hepatic dysfunction/steatosis [6,7] and
start to die from 2 weeks of age, and the majority die by 4 weeks
Table 1
Primer sets for qPCR.
Gene Primer sequence Size
Afp 50-CAGGCACTGTCCAAGCAAAG-30 (Forward) 218 bp
50-ATGAAAATGTCGGCCATTCC-30 (Reverse)
Apoe 50-TGCTGTTGGTCACATTGCTG-30 (Forward) 145 bp
50-CTGCAGCTCTTCCTGGACCT-30 (Reverse)
Apoa4 50-AACAATGCCAAGGAGGCTGT-30 (Forward) 132 bp
50-CTGCAGCTCTTCCTGGACCT-30 (Reverse)
A2m 50-CAGCAGCAGAAGGACAATGG-30 (Forward) 171 bp
50-CAGGCAAAAGAGGGCATTTC-30 (Reverse)
Cp 50-AGCATTCAGCCAATGGGAGT-30 (Forward) 148 bp
50-GTCCCATTTCTTTGGGGACA-30 (Reverse)
Itih4 50-CCCGATTTGCCCATACTGTT-30 (Forward) 162 bp
50-CGGCCTTCTCTTTGACAACC-30 (Reverse)
Hpx 50-ATAGCTGGCCCATTGCTCAT-30 (Forward) 161 bp
50-CTCCAGCCGCTTTGGATAAC-30 (Reverse)
Kng1 50-CACAGCAACTGTGGGGAAAA-30 (Forward) 124 bp
50-TATGGCATGCACACAACCAA-30 (Reverse)
Serpinc1 50-AACCGCCTTTTTGGAGACAA-30 (Forward) 120 bp
50-TCTGGATTGCTCCGGATTCT-30 (Reverse)
Serpina1c 50-TCTTCCTTCTGCCCGATGAT-30 (Forward) 120 bp
50-GTCTGGGGAAGTGGATCTGG-30 (Reverse)
Ahsg 50-AGATTTCCCGGGCTCAAAAT-30 (Forward) 156 bp
50-GCATGAGATTTGCCTTGCAG-30 (Reverse)
Gc 50-AGCACTCAGAGTCCCCTGCT-30 (Forward) 127 bp
50-TCCTTAGCCGTTCTGCCAAT-30 (Reverse)
Fgb 50-CACCTCCATCAAGCCGTACA-30 (Forward) 111 bp
50-TCCCATTTCCTGCCAAAGTC-30 (Reverse)
Fgg 50-CCTTCTTTGCTGCCTGCTTT-30 (Forward) 172 bp
50-CGTTCGGAGATCATTGTCCA-30 (Reverse)
Apoa1 50-TGTGTATGTGGATGCGGTCA-30 (Forward) 172 bp
50-ATCCCAGAAGTCCCGAGTCA-30 (Reverse)
Alb 50-AAAGACGTGTGTTGCCGATG-30 (Forward) 122 bp
50-AGCAGTCAGCCAGTTCACCA-30 (Reverse)
Zbtb20 50-CCTTCCCTGCCTGAACTTTG-30 (Forward) 176 bp
50-GCACGGAATTGCTGAAGTTG-30 (Reverse)
Hprt 50-GACTGATTATGGACAGGACTG-30 (Forward) 211 bp
50-GACTGATCATTACAGTAGCTC-30 (Reverse)
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1-, 2-, and 4-week-old Cbs/ and wild-type mice. Plasma protein
concentrations were signiﬁcantly lower in Cbs/ mice
(24.2 ± 4.5 lg/lL [n = 10] versus 37.2 ± 3.3 lg/lL [n = 8] in
wild-type mice at 2 weeks of age; P < 0.001), and equal volumes
of plasma samples were labeled ﬂuorescently and separated by
2D DIGE (n = 3 for each genotype/age). The obtained ﬂuorescent
images indicated that most plasma protein spots were downregu-
lated, whereas only few spots were upregulated in 2-week-old
Cbs/ mice (Fig. 1A), and such changes were not apparent in
1-week-old mice (Fig. 1B) but were generally maintained in
4-week-old mice (Fig. 1C).
MALDI-TOF/MS and Mascot search analyses identiﬁed a total of
48 spots for 16 protein species in the plasma samples (Table 2). AFP
variants (spots 1a–d) and apolipoprotein E (spot 2) were highly
expressed in 2-week-old Cbs/ mouse plasma, compared with
wild-type mouse plasma (Fig. 1A). In contrast, the expression
levels of other major plasma proteins, a-2-macroglobulin (spots
4a–f), ceruloplasmin (spots 5a–e), inter a-trypsin inhibitor, heavy
chain 4 (spots 6a–d), hemopexin (spots 7a–c), kininogen-1 (spots
8a–d), antithrombin-III (spot 9), a-1-antitrypsin 1-3 (spots 10a–
d), a-2-HS-glycoprotein (spots 11a–c), vitamin D-binding protein
(spot 12), ﬁbrinogen b chain (spot 13), ﬁbrinogen c chain (spots
14a–d), and apolipoprotein A-I (spots 15b/c) were signiﬁcantly
downregulated in 2-week-old Cbs/ mouse plasma (Fig. 1A).
Most plasma proteins had several variant spots that dispersed with
equal horizontal intervals in IEF; the spots had higher molecular
weights as they shifted to lower (acidic) conditions, suggesting
that they are redundantly sialylated and thus acidiﬁed.
Expression of apolipoprotein A-IV (spot 3) and A-I variant (spot15a) was similar between 2-week-old Cbs/ and wild-type mouse
samples (Fig. 1A), although the expression of both spots increased
in 4-week-old Cbs/ mouse samples (Fig. 1C). The amount of
albumin, the most abundant protein in plasma, did not differ sig-
niﬁcantly (51.1–57.0% [n = 4–6]) among 1-, 2-, and 4-week-old
wild-type and Cbs/ mice (data not shown). Taken together,
AFP was enriched whereas most other plasma proteins (except
albumin) had decreased levels just before most Cbs/ mice started
to die.
3.2. AFP expression in plasma (serum) and liver
Western blotting analysis using 2D PAGE identiﬁed nine
AFP-positive spots around 80–90 kDa and pI 5.3–5.8 ranges, and
all AFP spots were upregulated in 2-week-old Cbs/mouse plasma
(Fig. 2A). We next examined AFP expression levels in the serum/li-
ver of 2-week-old wild-type, Cbs heterozygous (Cbs+/), Cbs/,
Cth+/, and Cth/ mice. Serum and hepatic AFP levels were
3.5- and 7.3-fold, respectively, higher in Cbs/ mice than in
wild-type mice (Fig. 2B). AFP expression in Cth/ mouse serum
appeared slightly higher than in wild-type samples, but the differ-
ence was not signiﬁcant (Fig. 2B). We further investigated AFP
expression in serum and liver during postnatal development. AFP
was highly expressed in embryonic liver and serum, but its
expression was repressed postnatally (Fig. 2C). Compared with
2-week-old (P14.5: postnatal day 14.5) wild-type and Cbs+/ mice,
in which their hepatic AFP expression was completely repressed
and serum AFP expression was mostly repressed, substantial levels
of AFP expression were observed in both the liver and serum of
2-week-old Cbs/ mice (Fig. 2C).
3.3. Transcriptional regulation of plasma proteins
Hepatic mRNA expression of all identiﬁed genes was examined
by qPCR (Fig. 3). Afp expression levels were similar between
wild-type and Cbs/ mice at P0.5. Afp expression in wild-type
mice decreased dramatically at P14.5 (27.0-fold decrease from
P0.5) and P28.5 (1,260-fold decrease), whereas that in Cbs/ mice
increased at P7.5 (2.33-fold increase) and then decreased at P14.5
(2.23-fold decrease) and P28.5 (15.6-fold decrease). As a result, Afp
expression levels in Cbs/ mice were 2.16-, 10.2-, and 68.3-fold
higher than that in wild-type mice at P7.5, P14.5, and P28.5,
respectively. Protein expression of apolipoprotein E was increased
(Fig. 1A), but its mRNA expression level was decreased at P14.5 in
Cbs/ mice (Fig. 3). In addition, protein expression of apolipopro-
tein A-IV was higher in Cbs/ mice only at P28.5 (Fig. 1C), but its
mRNA expression levels were always higher that wild-type mice
(Fig. 3). The expression levels of all other genes whose protein
expression was signiﬁcantly lower in Cbs/ mouse plasma were
all decreased in Cbs/ mouse liver at P14.5 as well as at P28.5,
indicating that decreased expression of most plasma proteins is
attributable to their reduced mRNA expression in the liver. Xie
et al. previously reported that postnatal Afp expression in mouse
liver is repressed by the zinc ﬁnger protein ZBTB20 [13]. Hepatic
Zbtb20 expression was lower in Cbs/ mice, and therefore,
ZBTB20 may be involved in delayed Afp repression (Fig. 3).
4. Discussion
AFP is the major serum glycoprotein in the developing mam-
malian fetus that is produced by endodermal cells of the visceral
yolk sac and the liver. The Afp gene is highly activated in the fetal
liver but dramatically (10,000-fold) repressed soon after birth,
and only trace amounts are detectable in adults [13]. Serum AFP
elevation in adults is a well-known marker for hepatocellular
Fig. 1. Altered plasma protein proﬁles in juvenile Cbs/ mice revealed by 2D DIGE proteomic analysis. Plasma samples from wild-type (WT) and Cbs/ male mice (n = 3
each) at 2 (A), 1 (B), and 4 (C) weeks of age were analyzed comparatively. Representative ﬂuorescent image in which plasma samples fromWT and Cbs/ mouse plasma was
pseudocolored in green and red, respectively, are presented with approximate isoelectric points (pI) and molecular weights (kDa).
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[14,15]. The characteristic machinery of Afp repression has
attracted considerable attention from researchers interested in
transcriptional regulation [13,16,17]; however, despite over
50 years of research since its ﬁrst discovery in liver cancer, the
physiological functions of AFP still remain obscure [14,18]. The
main function of AFP is considered to be the extracellular transport
of small molecules including estrogens, fatty acids, and bilirubin
[19,20], but AFP-deﬁcient mice develop normally and thus AFP isdispensable for embryonic development [21]. Meanwhile AFP is
required for fertility in female mice [21] (i.e. protection of the
developing female brain from masculinization/defeminization by
estrogens [22]) and may play important immune regulatory roles
[19,20]. This is the ﬁrst demonstration of AFP accumulation during
juvenile development in CBS-deﬁcient mice, a homocystinuria
model that is widely utilized for homocysteine-related research
[5–8,12,23]. Our results may be clinically relevant because mark-
edly lower Cbs expression in 120 HCC specimens compared with
Table 2
Differentially expressed plasma proteins between 2-week-old wild-type and Cbs/ mice.
Spot ID Uniprot ID Unigene Protein (up or down regulated in Cbs/) Mascot score Sequence coverage (%) Peptide matches MWcalc pIcalc
1 a–d P02772 Afp a-fetoprotein (up) 218* 64* 36/104* 69,118 5.65
2 P08226 Apoe Apolipoprotein E (up) 172 46 20/36 35,901 5.56
3 P06728 Apoa4 Apolipoprotein A-IV (up at 4 weeks) 145 61 23/58 45,001 5.34
4 a–f Q61838 A2m a-2-macroglobulin (down) 73* 16* 14/39* 167,116 6.24
5 a–e Q61147 Cp Ceruloplasmin (down) 150* 31* 26/47* 121,872 5.53
6 a–d A6X935 Itih4 Inter a-trypsin inhibitor, heavy chain 4 (down) 100* 30* 25/79* 104,765 5.99
7 a–c Q91X72 Hpx Hemopexin (down) 115* 42* 18/84* 52,026 7.92
8 a–d O08677 Kng1 Kininogen-1 (down) 112* 26* 18/59* 74,140 6.05
9 P32261 Serpinc1 Antithrombin-III (down) 92 35 16/49 52,484 6.10
10 a–d Q00896 Serpina1c a-1-antitrypsin 1–3 (down) 97* 37* 11/41* 45,966 5.25
11 a–c P29699 Ahsg a-2-HS-glycoprotein (down) 72* 33* 9/34* 38,100 6.04
12 P21614 Gc Vitamin D-binding protein (down) 121 47 16/61 55,162 5.39
13 Q8K0E8 Fgb Fibrinogen b chain (down) 174 60 35/120 55,402 6.68
14 a–d Q8VCM7 Fgg Fibrinogen c chain (down) 212* 71* 24/45* 50,044 5.54
15 a–c Q00623 Apoa1 Apolipoprotein A-I (down) 195* 50* 20/51* 30,597 5.51
16 a–c P07724 Alb Serum albumin (no change) 263* 60* 31/72* 70,700 5.75
A total 16 proteins identiﬁed from MALDI-TOF/MS analysis and Mascot searches are listed with their spot ID (in Fig. 1A), Uniprot ID, Unigene/protein names, Mascot score,
sequence coverage, peptide matches, MWcalc (molecular weight calculated from identiﬁed protein sequence), and pIcalc (isoelectric point calculated from identiﬁed protein
sequence).
* Protein has some variant spots and the representative data from spots with the highest Mascot score are shown.
Fig. 2. Increased a-fetoprotein (AFP) expression in 2-week-old Cbs/ mouse plasma/serum/liver. (A) Two-dimensional PAGE/western blotting analysis of AFP variants in 2-
week-old wild-type (WT) and Cbs/ male mouse plasma (10 lL). (B) PAGE/western blotting analysis of AFP proteins in 2-week-old WT, (heterozygous) Cbs+/, Cbs/, Cth+/,
and Cth/ mouse serum and liver (2.5 lg protein per lane). As for liver samples, GAPDH expression was examined as a loading control. Band intensities of 79 kDa AFP
proteins were densitometrically scanned and the relative values against the average AFP expression level (for serum) or the AFP/GAPDH ratio (for liver) in WT mouse samples
were calculated. The representative band images are presented. Bar data show means ± SD (n = 3 each) and differences versus WT are signiﬁcant at *P < 0.05 and **P < 0.01 by
Student’s t-test. (C) PAGE/western blotting analysis of AFP proteins in embryonic day 15.5 (E15.5), postnatal day 0.5 (P0.5), P7.5, and P14.5 WT, Cbs+/, and Cbs/ mouse
serum and liver (2.5 lg protein per lane). Postnatal repression of AFP expression was delayed in Cbs/ mouse liver, and thus in Cbs/ mouse serum.
S. Kamata et al. / FEBS Open Bio 5 (2015) 535–541 539surrounding non-cancer liver cells was found to be associated with
high tumor stage and serum AFP level [24], and serum AFP eleva-
tion was found in NAFLD patients [25].Previous studies demonstrated that human AFP contains a sin-
gle glycosylation site but its structure varies with developmental
stage and disease state, probably by alternating glycosylation
Fig. 3. Gene expression analysis of differentially expressed proteins and ZBTB20 in 2-week-old Cbs/ mouse plasma by qPCR. Hepatic mRNA levels of a-fetoprotein (Afp),
apolipoprotein E (Apoe), apolipoprotein A-IV (Apoa4), a-2-macroglobulin (A2m), ceruloplasmin (Cp), inter a-trypsin inhibitor, heavy chain 4 (itih4), hemopexin (Hpx), kininogen-1
(Kng1), antithrombin-III (Serpinc1), a-1-antitrypsin 1-3 (Serpina1c), a-2-HS-glycoprotein (Ahsg), vitamin D-binding protein (Gc), ﬁbrinogen b chain (Fgb), ﬁbrinogen c chain (Fgg),
apolipoprotein A-I (Apoa1), albumin (Alb), and Zbtb20 were analyzed by qPCR and normalized by hypoxanthine guanine phosphoribosyl transferase (Hprt) expression. The
expression levels in wild-type mice (Wt) at postnatal day 0.5 (P0.5) (for Afp and Zbtb20) or P7.5 (for others) were set at 1. Data are shown as means ± SD (n = 4–6), and
differences are signiﬁcant in *P < 0.05, **P < 0.01 and ***P < 0.001 versus P0.5 (for Afp and Zbtb20) or P7.5 (for others); and #P < 0.05, ##P < 0.01 and ###P < 0.001 versus
respective Wt samples by t-test.
540 S. Kamata et al. / FEBS Open Bio 5 (2015) 535–541status [26,27]. Lens culinaris agglutinin (LCA)-reactive fraction of
AFP (AFP-L3) has been considered as a more speciﬁc HCC marker
[27]. In this study, we detected hyperaccumulation of all nine
AFP variants in 2-week-old Cbs/ mouse plasma compared with
respective wild-type samples (Fig. 2A), which was attributable to
delayed repression of Afp expression in the liver (Fig. 2C). In con-
trast, expression of most other major plasma proteins was sup-
pressed (Table 2 and Fig. 1A), at least partly, via transcriptional
repression (Fig. 3). One plausible explanation is that increased
AFP may bind and hold multiple endogenous ligands required for
transcriptional activation of such liver proteins. This is because
AFP belongs to a three-domain albuminoid gene family that cur-
rently consists of four members (AFP, albumin, vitamin
D-binding protein, and a-albumin) and binds steroids, fatty acids,
bilirubin, retinoids, and heavy metals [19,20]. Indeed, vitaminD-binding protein, which binds/transports vitamin D and plays
important roles in bone/calcium homeostasis [28], was downregu-
lated in 2-week-old Cbs/ mouse plasma (Table 2 and Fig. 1A).
This downregulation could be related to osteoporosis and skeletal
abnormalities found in Cbs/ mice [29], although transgenic mice
overexpressing human AFP were found to be generally normal
[30], and hereditary persistence of AFP in two unrelated Japanese
families exhibited no apparent phenotypes [31]. We reported pre-
viously about abnormal and decreased high-density lipoprotein
contents in 2-week-old Cbs/ mouse serum [7], which may be
associated with decreased apolipoprotein A-I levels (Table 2 and
Fig. 1A).
In conclusion, we found transcriptionally regulated hyperaccu-
mulation of AFP in fatty liver and plasma of juvenile Cbs/ mice.
Mice lacking methionine adenosyltransferase 1A also displayed
S. Kamata et al. / FEBS Open Bio 5 (2015) 535–541 541both fatty liver and AFP accumulation [32], but our Cth/ mice did
not [9]; therefore, the methionine cycle/transsulfuration pathway
may play important roles in epigenetic regulation of Afp.
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